Position in ARQT
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,185,044
-$688,006 QoQ
Shares Held
50,299
-22.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Phocas Financial Corp. holds $6,718,190 across 5 Biotechnology names. ARQT ranks #4 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
81,347 | $1,810,784 | |
| 2 | ZVRA |
Zevra Therapeutics, Inc.
|
159,423 | $1,485,822 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
19,875 | $1,354,083 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
50,299 | $1,185,044 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
97,942 | $882,457 |
All Filings in ARQT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,185,044 | 50,299 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,873,050 | 64,499 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,003,886 | 106,307 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,458,276 | 104,014 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,626,544 | 103,999 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||